Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

 64.60p
   
  • Change Today:
      0.000p
  • 52 Week High: 64.60p
  • 52 Week Low: 29.35p
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 5,894,213
  • Market Cap: £349.21m
  • RiskGrade: 119
  • Beta: 0.01

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Andrew Franklin 248,503 £160,533
Richard Jones 68,000 £43,928

Major Shareholders

Notifier** Holding Value*
DBAY Advisors Limited 151,076,240 £97,595,251
Kempen Capital Management N.V. 55,157,348 £35,631,647
Sand Grove Capital Management LLP 53,933,863 £34,841,276
MVM Life Science Partners 40,561,900 £26,202,987
Glazer Capital, LLC 35,604,587 £23,000,563
Blackrock, Inc. 32,282,356 £20,854,402
Rathbone Investment Mgt 25,968,567 £16,775,694
GVQ Investment Management Ltd 23,691,460 £15,304,683
Slater Investments Ltd 23,622,703 £15,260,266
Polar Capital 23,252,692 £15,021,239
Royal Bank of Canada 20,645,236 £13,336,822
Investec Asset Management 19,844,776 £12,819,725
Aviva plc & its subsidiaries 18,255,256 £11,792,895
Lombard Odier Asset Management (Europe) Limited 16,761,194 £10,827,731
Artemis Investment Management LLP 16,304,802 £10,532,902
John Dawson 16,200,462 £10,465,498
Stella Anne Dawson 15,576,323 £10,062,305
Old Mutual Asset Managers (UK) Ltd 7,488,920 £4,837,842

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.60p
Change Today 0.000p
% Change 0.00 %
52 Week High 64.60p
52 Week Low 29.35p
Volume 5,894,213
Shares Issued 540.57m
Market Cap £349.21m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average24.24% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Price Trend
74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average74.42% above the market average
91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average91.67% above the sector average
Income Not Available
Growth
49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average49.61% below the market average
68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average68.75% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 08-May-2025

Time Volume / Share Price
16:35 222,736 @ 64.60p
16:35 924 @ 64.60p
16:35 810 @ 64.60p
16:35 1,700 @ 64.60p
16:35 1,734 @ 64.60p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page